FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joseph Aisner

Research Profile

Disorders

Procedures

Chemicals & Drugs

Activities & Behaviors

Drug Evaluation

Concepts & Ideas

Drug Administration Schedule

Co-author Network

Publications

TOP 3
Seena Aisner; Suzanne Dahlberg; Meera Hameed; David S Ettinger; Joan H Schiller; David H Johnson; Joseph Aisner; Patrick J Loehrer
Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperative Oncology Group study.
Roger K Strair; Mecide Gharibo; Dale Schaar; Arnold Rubin; Jonathan Harrison; Joseph Aisner; Hsin-Ching Lin; Yong Lin; Lauri Goodell; Monika Anand; Binaifer Balsara; Liesel Dudek; Arnold Rabson; Medina Daniel
Nuclear factor-kappaB modulation in patients undergoing induction chemotherapy for acute myelogenous leukemia.
Biren Saraiya; Murugesan K Gounder; Jayeeta Dutta; Ahamed Saleem; Celeste Collazo; Luz Zimmerman; Ahamed Nazar; Mecide Gharibo; Dale Schaar; Yong Lin; Weichung Shih; Joseph Aisner; Roger K Strair; Eric H Rubin
Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joseph Aisner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Seena Aisner; Suzanne Dahlberg; Meera Hameed; David S Ettinger; Joan H Schiller; David H Johnson; Joseph Aisner; Patrick J Loehrer
Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperative Oncology Group study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(6):885-92.
2008: Roger K Strair; Mecide Gharibo; Dale Schaar; Arnold Rubin; Jonathan Harrison; Joseph Aisner; Hsin-Ching Lin; Yong Lin; Lauri Goodell; Monika Anand; Binaifer Balsara; Liesel Dudek; Arnold Rabson; Medina Daniel
Nuclear factor-kappaB modulation in patients undergoing induction chemotherapy for acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7564-8.
2008: Biren Saraiya; Murugesan K Gounder; Jayeeta Dutta; Ahamed Saleem; Celeste Collazo; Luz Zimmerman; Ahamed Nazar; Mecide Gharibo; Dale Schaar; Yong Lin; Weichung Shih; Joseph Aisner; Roger K Strair; Eric H Rubin
Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia.
Anti-cancer drugs 2008;19(4):411-20.
2007: Joseph Aisner
CT screening for lung cancer: are we ready for wide-scale application?
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(17):4951-3.
2007: Joseph Aisner
Overview of the changing paradigm in cancer treatment: oral chemotherapy.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2007;64(9 Suppl 5):S4-7.
2007: Susan Goodin; Joseph Aisner; Sylvia B Bartel; Carol S Viele
Current issues associated with oral chemotherapy: a roundtable discussion.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2007;64(9 Suppl 5):S33-5.
2007: Susan Goodin; Francisco Shen; Weichung Joe Shih; Nisha Dave; Michael P Kane; Patrick Medina; George H Lambert; Joseph Aisner; Michael Gallo; Robert S DiPaola
Clinical and biological activity of soy protein powder supplementation in healthy male volunteers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(4):829-33.
2006: David S Ettinger; Joseph Aisner
Changing face of small-cell lung cancer: real and artifact.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(28):4526-7.
2006: Mika A Sovak; Stuart Lutzker; Ling Zheng; Lisa Guensch; Margaret M. Joyce; Susan Schwartz; Yujun Wu; Joseph Aisner
Rational drug sequencing of paclitaxel, gemcitabine and carboplatin in patients with untreated stage IV and select stage IIIB non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2006;53(2):177-81.
2006: Dale Schaar; Lauri Goodell; Joseph Aisner; Xiao-Xing Cui; Zheng Tao Han; Richard Chang; John Martin; Stephanie Grospe; Liesel Dudek; Joan Riley; Jacqueline Manago; Yong Lin; Eric H Rubin; Allan H Conney; Roger K Strair
A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies.
Cancer chemotherapy and pharmacology 2006;57(6):789-95.
2005: Joseph Aisner
Targeting COX-2/PG-E2 with a COX-2 inhibitor in combination with chemotherapy for non-small cell lung cancer: are we ready for phase III?
Cancer journal (Sudbury, Mass.) 2005;11(3):201-3.
2003: Roger K Strair; Dale Schaar; Daniel Medina; Mary B Todd; Joseph Aisner; Robert S DiPaola; Jacqueline Manago; Beth Knox; Amanda Jenkinson; Rachelle Senzon; Christina Baker; Dudek Liesel; Marie Ciardella; Mercy Kuriyan; Arnold Rubin; Edmund C Lattime
Antineoplastic effects of partially HLA-matched irradiated blood mononuclear cells in patients with renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3785-91.
2003: Joseph Aisner; Rita Musanti; Stephanie Beers; Sharon Smith; Stephanie Locsin; Eric H Rubin
Sequencing topotecan and etoposide plus cisplatin to overcome topoisomerase I and II resistance: a pharmacodynamically based Phase I trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2504-9.
2003: Edward J Licitra; Viral Vyas; Kathleen Bickel; Rita Musanti; Stephanie Beers; Cecilia Thomas; Elizabeth Poplin; Sharon Smith; Yong Lin; Larry J Schaaf; Joseph Aisner; Murugesan K Gounder; Rajeev Rajendra; Ahamed Saleem; Deborah Toppmeyer; Eric H Rubin
Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1673-9.
2003: Howard L Parnes; Constance Cirrincione; Joseph Aisner; Donald A Berry; Steven Allen; Jeffrey Abrams; E Chuang; M Robert Cooper; Michael C Perry; David B Duggan; T P Szatrowski; I Craig Henderson; Larry Norton
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1819-24.
2002: Roger K Strair; Dale Schaar; Lauri Goodell; Joseph Aisner; Khew-Voon Chin; Joseph Eid; Rachelle Senzon; Xiao-Xing Cui; Zheng Tao Han; Beth Knox; Arnold B Rabson; Richard Chang; Allan H Conney
Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(8):2512-8.
2002: Richard A Drachtman; Peter Cole; Carla B Golden; S Jill James; Stepan Melnyk; Joseph Aisner; Barton A. Kamen
Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity.
Pediatric hematology and oncology 2002;19(5):319-27.
2002: Christian Manegold; Joseph Aisner
Pemetrexed for diffuse malignant pleural mesothelioma.
Seminars in oncology 2002;29(2 Suppl 5):30-5.
2002: Donald A Berry; Gloria Broadwater; John P Klein; Karen Antman; Joseph Aisner; Jacob Bitran; Mary Costanza; Cesar O Freytes; Edward A Stadtmauer; Robert Peter Gale; I Craig Henderson; Hillard M Lazarus; Philip L McCarthy; Larry Norton; Howard L Parnes; Andrew L Pecora; Michael C Perry; Philip Rowlings; Gary Spitzer; Mary M Horowitz
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):743-50.
2001: Robert S DiPaola; E S Chenven; Weichung Joe Shih; Yong Lin; Peter S Amenta; Susan Goodin; A Shumate; Terry Capanna; M Cardiella; Kenneth B Cummings; Joseph Aisner; Mary B Todd
Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma.
Cancer 2001;92(8):2065-71.
2001: Patrick J Loehrer; M Jiroutek; Seena Aisner; Joseph Aisner; M Green; Charles Thomas; R Livingston; David H Johnson
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
Cancer 2001;91(11):2010-5.
2000: Barton A. Kamen; E Rubin; Joseph Aisner; E Glatstein
High-time chemotherapy or high time for low dose.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(16):2935-7.
2000: D Kaufman; D Raghavan; Michael A Carducci; E G Levine; B Murphy; Joseph Aisner; T Kuzel; S Nicol; William K Oh; W Stadler
Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1921-7.
2000: Mohan Suntharalingam; ML Haas; BA Conley; Merrill J Egorin; S Levy; S Sivasailam; JOSEPH HERMAN; M C Jacobs; William C Gray; Robert A Ord; Joseph Aisner; David A Van Echo
The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.
International journal of radiation oncology, biology, physics 2000;47(1):49-56.
1999: Anne Aupérin; Rodrigo Arriagada; Jean-Pierre Pignon; Cécile Le Péchoux; Anna Gregor; Richard J Stephens; Paul E.G. Kristjansen; Bruce E Johnson; H Ueoka; H Wagner; Joseph Aisner
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.
The New England journal of medicine 1999;341(7):476-84.
1999: Nicholas J Vogelzang; James E Herndon; A Miller; G Strauss; Gerald Clamon; F M Stewart; Joseph Aisner; A Lyss; M Robert Cooper; Y Suzuki; Mark R Green
High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):597-600.
1999: Robert S DiPaola; Joseph Aisner
Overcoming bcl-2- and p53-mediated resistance in prostate cancer.
Seminars in oncology 1999;26(1 Suppl 2):112-6.
1999: Chandra P Belani; C M Kearns; Eleanor G Zuhowski; K Erkmen; D Hiponia; D Zacharski; C Engstrom; Ramesh K Ramanathan; Mary Jo Capozzoli; Joseph Aisner; Merrill J Egorin
Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):676-84.
1999: Jeffrey Abrams; Joseph Aisner; Constance Cirrincione; Donald A Berry; Hyman Muss; M Robert Cooper; I Craig Henderson; L Panasci; J Kirshner; J Ellerton; Larry Norton
Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):64-73.
1998: Tim A Ahles; Peter M Silberfarb; James Herndon; LH Maurer; Alice B Kornblith; Joseph Aisner; Michael C Perry; WL Eaton; L L Zacharski; Mark R Green; Jimmie C Holland
Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1954-60.
1998: B L Samuels; J E Herndon; D C Harmon; R Carey; Joseph Aisner; J M Corson; Y Suzuki; Mark R Green; Nicholas J Vogelzang
Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.
Cancer 1998;82(8):1578-84.
1997: Margaret A Tucker; N Murray; Edward G Shaw; David S Ettinger; M Mabry; M H Huber; R Feld; F A Shepherd; D H Johnson; S C Grant; Joseph Aisner; Bruce E Johnson
Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre.
Journal of the National Cancer Institute 1997;89(23):1782-8.
1997: Robert S DiPaola; R E Weiss; Kenneth B Cummings; Fengming P Kong; R L Jirtle; Mitchell S. Anscher; J Gallo; Susan Goodin; S Thompson; Zeshaan A Rasheed; Joseph Aisner; Mary B Todd
Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigen.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(11):1999-2004.
1997: LH Maurer; James E Herndon; D R Hollis; Joseph Aisner; RW Carey; Arthur T Skarin; Michael C Perry; WL Eaton; L L Zacharski; S Hammond; Mark R Green
Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(11):3378-87.
1997: BA Conley; M Jacobs; Mohan Suntharalingam; D Zacharski; Robert A Ord; W Gray; Joseph Aisner
A pilot trial of paclitaxel, carboplatin, and concurrent radiotherapy for unresectable squamous cell carcinoma of the head and neck.
Seminars in oncology 1997;24(1 Suppl 2):S2-78-S2-80.
1997: Hernán Cortés-Funes; Joseph Aisner
Paclitaxel in head and neck cancer and other tumor types: chairmen's introduction.
Seminars in oncology 1997;24(1 Suppl 2):S2-51-S2-57.
1997: Joseph Aisner; Hernán Cortés-Funes
Paclitaxel in head and neck and other cancers: future prospects.
Seminars in oncology 1997;24(1 Suppl 2):S2-113-S2-115.
1996: Chandra P Belani; Joseph Aisner; Sanjeev Bahri; J Jett; R Day; M J Capazolli; D Hiponia; C Engstrom
Chemoradiotherapy in non-small cell lung cancer: paclitaxel/carboplatin/radiotherapy in regionally advanced disease.
Seminars in oncology 1996;23(6 Suppl 16):113-6.
1996: Chandra P Belani; Joseph Aisner; D Hiponia; Ramesh K Ramanathan
Paclitaxel and carboplatin in metastatic non-small cell lung cancer: preliminary results of a phase I study.
Seminars in oncology 1996;23(5 Suppl 12):19-21.
1996: Joseph Aisner
Extensive-disease small-cell lung cancer: the thrill of victory; the agony of defeat.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):658-65.
1995: Joseph Aisner; Chandra P Belani; C Kearns; BA Conley; D Hiponia; C Engstrom; Eleanor G Zuhowski; Merrill J Egorin
Feasibility and pharmacokinetics of paclitaxel, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non-small cell lung cancer.
Seminars in oncology 1995;22(5 Suppl 12):17-21.
1995: C M Kearns; Chandra P Belani; K Erkmen; M Zuhowski; D Hiponia; D Zacharski; C Engstrom; Ramesh K Ramanathan; M R Trenn; Joseph Aisner
Pharmacokinetics of paclitaxel and carboplatin in combination.
Seminars in oncology 1995;22(5 Suppl 12):1-4; discussion 5-7.
1995: Chandra P Belani; Joseph Aisner; D Hiponia; C Engstrom
Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancer.
Seminars in oncology 1995;22(4 Suppl 9):7-12.
1995: Joseph Aisner
Current approach to malignant mesothelioma of the pleura.
Chest 1995;107(6 Suppl):332S-344S.
1995: Joseph Aisner; Constance Cirrincione; M Perloff; M Perry; D Budman; J Abrams; L Panasci; Hyman Muss; M Citron; Jimmie C Holland
Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1443-52.
1995: Joseph Aisner; D Hiponia; BA Conley; M Jacobs; W Gray; Chandra P Belani
Combined modalities in the treatment of head and neck cancers.
Seminars in oncology 1995;22(3 Suppl 6):28-34.
1994: Joseph Aisner; M Jacobs; V Sinabaldi; W Gray; Mario A Eisenberger
Chemoradiotherapy for the treatment of regionally advanced head and neck cancers.
Seminars in oncology 1994;21(5 Suppl 12):35-44.
1994: Chandra P Belani; Joseph Aisner
Combined chemotherapy and radiation in locally advanced non-small cell lung cancer.
Seminars in oncology 1994;21(3 Suppl 6):79-90.
1994: P A Bunn; nico van zandwijk; U Pastorino; Joseph Aisner; P Alberto; Rodrigo Arriagada; D Carney; R Cornis; C Dittrich; U Gatzemeier
European School of Oncology. First Euro-American Forum on Lung Cancer Treatment.
European journal of cancer (Oxford, England : 1990) 1994;30A(5):710-3.
1994: Chandra P Belani; L Austin Doyle; Joseph Aisner
Etoposide: current status and future perspectives in the management of malignant neoplasms.
Cancer chemotherapy and pharmacology 1994;34 Suppl():S118-26.
1993: Alice B Kornblith; D R Hollis; Enid Zuckerman; A P Lyss; George P Canellos; M Robert Cooper; J E Herndon; C A Phillips; J Abrams; Joseph Aisner
Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(11):2081-9.
1993: Joseph Aisner; Chandra P Belani
Lung cancer: recent changes and expectations of improvements.
Seminars in oncology 1993;20(4):383-93.
1993: A P Chahinian; K Antman; M Goutsou; J M Corson; Y Suzuki; C Modeas; J E Herndon; Joseph Aisner; R R Ellison; L Leone
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(8):1559-65.
1993: Joseph Aisner
Breast cancer therapy in the elderly.
JAMA : the journal of the American Medical Association 1993;270(3):391.
1993: J S Abrams; Julie L Eiseman; T J Melink; R Sridhara; D J Hiponia; M M Bell; Chandra P Belani; W H Adler; Joseph Aisner
Immunomodulation of interleukin-2 by cyclophosphamide: a phase IB trial.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;14(1):56-64.
1993: Joseph Aisner; P H Wiernik; P Pearl
Pregnancy outcome in patients treated for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):507-12.
1992: Joseph Aisner
Treatment of limited-disease small cell lung cancer.
Seminars in oncology 1992;19(6 Suppl 13):51-8.
1992: H L Parnes; Joseph Aisner
Protein calorie malnutrition and cancer therapy.
Drug safety : an international journal of medical toxicology and drug experience 1992;7(6):404-16.
1992: Chandra P Belani; Joseph Aisner
Combined-modality therapies for non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 3():3-10.
1992: Joseph Aisner; M Goutsou; LH Maurer; R Cooper; P Chahinian; R Carey; A Skarin; Robert Slawson; M C Perry; Mark R Green
Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(8):1230-6.
1992: N S Tchekmedyian; M Hickman; J Siau; F A Greco; J Keller; H Browder; Joseph Aisner
Megestrol acetate in cancer anorexia and weight loss.
Cancer 1992;69(5):1268-74.
1992: Joseph Aisner; Victoria Sinibaldi; Mario A Eisenberger
Carboplatin in the treatment of squamous cell head and neck cancers.
Seminars in oncology 1992;19(1 Suppl 2):60-5.
1992: J S Abrams; J Gutheil; Joseph Aisner
Potential applications of high-dose megestrol acetate in breast cancer.
Oncology 1992;49 Suppl 2():12-7.
1992: Joseph Aisner; M Y Whitacre; D R Budman; Kathleen J Propert; G Strauss; David A Van Echo; M Perry
Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer.
Cancer chemotherapy and pharmacology 1992;29(6):435-8.
1992: Joseph Aisner
Current approaches to small cell lung cancer.
Hematological oncology 1992;10(1):7-20.
1991: E G Elias; D A Vachon; MUKUND DIDOLKAR; Joseph Aisner
Long-term results of a combined modality approach in treating inflammatory carcinoma of the breast.
American journal of surgery 1991;162(3):231-5.
1991: H L Parnes; J S Abrams; N S Tchekmedyian; N Tait; Joseph Aisner
A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer.
Breast cancer research and treatment 1991;18(3):171-7.
1991: H L Parnes; J S Abrams; N Tait; J Minford; Steven Allen; D Duggan; Joseph Aisner
Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinoma.
Journal of the National Cancer Institute 1991;83(14):1017-20.
1991: Joseph Aisner; Edward J Lee
Etoposide. Current and future status.
Cancer 1991;67(1 Suppl):215-9.
1990: Joseph Aisner; H Parnes; N Tait; M Hickman; A Forrest; F A Greco; N S Tchekmedyian
Appetite stimulation and weight gain with megestrol acetate.
Seminars in oncology 1990;17(6 Suppl 9):2-7.
1990: J S Abrams; H Parnes; Joseph Aisner
Current status of high-dose progestins in breast cancer.
Seminars in oncology 1990;17(6 Suppl 9):68-72.
1990: I N Olver; P Pearl; P H Wiernik; Joseph Aisner
Small bowel obstruction as a late complication of the treatment of Hodgkin's disease.
The Australian and New Zealand journal of surgery 1990;60(8):585-8.
1990: N S Tchekmedyian; M Hickman; J Siau; A Greco; Joseph Aisner
Treatment of cancer anorexia with megestrol acetate: impact on quality of life.
Oncology (Williston Park, N.Y.) 1990;4(5):185-92; discussion 194.
1990: A Elias; L Ryan; Joseph Aisner; Karen Antman
Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma.
Seminars in oncology 1990;17(2 Suppl 4):41-9.
1990: Chandra P Belani; Joseph Aisner
Therapy for small cell and non-small cell lung cancer.
Current opinion in oncology 1990;2(2):334-44.
1990: D R Budman; A H Korzun; Joseph Aisner; J Younger; R Silver; M Costanza; M A Rice; W Wood
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443.
Cancer investigation 1990;8(6):571-5.
1990: Nicholas J Vogelzang; M Goutsou; J M Corson; Y Suzuki; Stephen L Graziano; Joseph Aisner; M Robert Cooper; K M Coughlin; Mark R Green
Carboplatin in malignant mesothelioma: a phase II study of the Cancer and Leukemia Group B.
Cancer chemotherapy and pharmacology 1990;27(3):239-42.
1989: Chandra P Belani; Merrill J Egorin; J S Abrams; D Hiponia; Mario A Eisenberger; Joseph Aisner; David A Van Echo
A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(12):1896-902.
1989: Chandra P Belani; David A Van Echo; Joseph Aisner
Platinum compounds.
Current opinion in oncology 1989;1(2):186-91.
1989: Mario A Eisenberger; S Krasnow; S Ellenberg; H Silva; J Abrams; Victoria Sinibaldi; David A Van Echo; Joseph Aisner
A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(9):1341-5.
1989: A Elias; L Ryan; A Sulkes; J Collins; Joseph Aisner; Karen Antman
Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(9):1208-16.
1989: N O Whitley; Chandra P Belani; Joseph Aisner; A Forrest; J Whitley
Tumor volume and treatment outcome in small cell lung carcinoma.
Investigative radiology 1989;24(8):581-4.
1989: Joseph Aisner; J Abrams
Cisplatin for small-cell lung cancer.
Seminars in oncology 1989;16(4 Suppl 6):2-9.
1989: Joseph Aisner
Therapeutic approach to malignant mesothelioma.
Chest 1989;96(1 Suppl):95S-97S.
1989: Joseph Aisner
Should we intensify the treatment of small cell lung cancer?
Chest 1989;96(1 Suppl):64S-66S.
1989: J P Dutcher; J Kendall; D Norris; Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Granulocyte transfusion therapy and amphotericin B: adverse reactions?
American journal of hematology 1989;31(2):102-8.
1989: N Tait; Joseph Aisner
Nutritional concerns in cancer patients.
Seminars in oncology nursing 1989;5(2 Suppl 1):58-62.
1989: H Parnes; N Tait; Joseph Aisner
The potential of megestrol acetate in the treatment of cancer cachexia.
Nutrition (Burbank, Los Angeles County, Calif.) 1989;5(3):206-9.
1989: Mario A Eisenberger; David A Van Echo; Joseph Aisner
Carboplatin: the experience in head and neck cancer.
Seminars in oncology 1989;16(2 Suppl 5):34-41.
1989: David A Van Echo; Merrill J Egorin; Joseph Aisner
The pharmacology of carboplatin.
Seminars in oncology 1989;16(2 Suppl 5):1-6.
1989: J S Abrams; N Tait; H Silva; Mario A Eisenberger; David A Van Echo; Ian N Olver; Joseph Aisner
Phase II trial of N-methylformamide in advanced renal cancer.
American journal of clinical oncology 1989;12(1):41-2.
1989: Chandra P Belani; P Pearl; N O Whitley; Joseph Aisner
Tamoxifen withdrawal response. Report of a case.
Archives of internal medicine 1989;149(2):449-50.
1989: Joseph Aisner; N O Whitley
Current staging of lung cancer: an overview of current and newer approaches.
Cancer treatment and research 1989;45():183-213.
1988: Ian N Olver; Joseph Aisner; A Hament; Laura Buchanan; JF Bishop; Richard S. Kaplan
A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(11):1732-5.
1988: J Abrams; L Austin Doyle; Joseph Aisner
Staging, prognostic factors, and special considerations in small cell lung cancer.
Seminars in oncology 1988;15(3):261-77.
1988: I Kostrubiak; N O Whitley; Joseph Aisner; P Goose; R R DeLuca; MUKUND DIDOLKAR; E G Elias
The use of computed body tomography in malignant melanoma.
JAMA : the journal of the American Medical Association 1988;259(19):2896-7.
1988: N S Tchekmedyian; N Tait; J Abrams; Joseph Aisner
High-dose megestrol acetate in the treatment of advanced breast cancer.
Seminars in oncology 1988;15(2 Suppl 1):44-9.
1988: Joseph Aisner; N S Tchekmedyian; N Tait; H Parnes; M Novak
Studies of high-dose megestrol acetate: potential applications in cachexia.
Seminars in oncology 1988;15(2 Suppl 1):68-75.
1988: Anne W Hamburger; H Parnes; G B Gordon; L M Shantz; K A O'Donnell; Joseph Aisner
Megestrol acetate-induced differentiation of 3T3-L1 adipocytes in vitro.
Seminars in oncology 1988;15(2 Suppl 1):76-8.
1988: Joseph Aisner
Combined modalities in the treatment of small cell carcinoma of the lung. A review of current standings.
Antibiotics and chemotherapy 1988;41():142-9.
1987: Joseph Aisner
Identification of new drugs in small cell lung cancer: phase II agents first?
Cancer treatment reports 1987;71(12):1131-3.
1987: Chandra P Belani; Mario A Eisenberger; David A Van Echo; D Hiponia; Joseph Aisner
Phase II study of caracemide in advanced or recurrent non-small cell lung cancer.
Cancer treatment reports 1987;71(11):1099-100.
1987: J F Bishop; Charles Alan Schiffer; Joseph Aisner; J P Matthews; P H Wiernik
Surgery in acute leukemia: a review of 167 operations in thrombocytopenic patients.
American journal of hematology 1987;26(2):147-55.
1987: M C Perry; C G Kardinal; A H Korzun; S J Ginsberg; P C Raich; James F Holland; R R Ellison; S Kopel; A Schilling; Joseph Aisner
Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B protocol 8081.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(10):1534-45.
1987: Joseph Aisner; V Weinberg; M Perloff; R Weiss; M Perry; A Korzun; S Ginsberg; James F Holland
Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(10):1523-33.
1987: BA Conley; J Hornedo; J Abrams; Mario A Eisenberger; D Hiponia; Joseph Aisner; David A Van Echo
Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.
Cancer treatment reports 1987;71(9):861-2.
1987: Stuart E Mirvis; N O Whitley; Joseph Aisner; M Moody; M Whitacre; J E Whitley
Abdominal CT in the staging of small-cell carcinoma of the lung: incidence of metastases and effect on prognosis.
AJR. American journal of roentgenology 1987;148(5):845-7.
1987: Joseph Aisner; N S Tchekmedyian; M Moody; N Tait
High-dose megestrol acetate for the treatment of advanced breast cancer: dose and toxicities.
Seminars in hematology 1987;24(2 Suppl 1):48-55.
1987: N S Tchekmedyian; N Tait; M Moody; Joseph Aisner
High-dose megestrol acetate. A possible treatment for cachexia.
JAMA : the journal of the American Medical Association 1987;257(9):1195-8.
1987: E Poplin; B Thompson; M Whitacre; Joseph Aisner
Small cell carcinoma of the lung: influence of age on treatment outcome.
Cancer treatment reports 1987;71(3):291-6.
1987: Merrill J Egorin; L M Sigman; David A Van Echo; A Forrest; M Y Whitacre; Joseph Aisner
Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion.
Cancer research 1987;47(2):617-23.
1986: N S Tchekmedyian; N Tait; M Moody; F A Greco; Joseph Aisner
Appetite stimulation with megestrol acetate in cachectic cancer patients.
Seminars in oncology 1986;13(4 Suppl 4):37-43.
1986: N S Tchekmedyian; N Tait; Joseph Aisner
High-dose megestrol acetate in the treatment of postmenopausal women with advanced breast cancer.
Seminars in oncology 1986;13(4 Suppl 4):20-5.
1986: S T Orr; Joseph Aisner
Performance status assessment among oncology patients: a review.
Cancer treatment reports 1986;70(12):1423-9.
1986: N S Tchekmedyian; N Tait; David A Van Echo; Joseph Aisner
High-dose chemotherapy without autologous bone marrow transplantation in melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(12):1811-8.
1986: Joseph Aisner; M Whitacre; J Abrams; K Propert
Doxorubicin, cyclophosphamide, etoposide and platinum, doxorubicin, cyclophosphamide and etoposide for small-cell carcinoma of the lung.
Seminars in oncology 1986;13(3 Suppl 3):54-62.
1986: J S Abrams; J S Cunat; N O Whitley; J Z Fuks; Joseph Aisner
CT evaluation of patients during treatment of advanced non-small cell lung carcinoma.
American journal of clinical oncology 1986;9(4):292-8.
1986: B E Cohen; Merrill J Egorin; E A Kohlhepp; Joseph Aisner; Peter L Gutierrez
Human plasma pharmacokinetics and urinary excretion of thiotepa and its metabolites.
Cancer treatment reports 1986;70(7):859-64.
1986: S T Orr; Joseph Aisner
Treatment approaches for lung cancer patients in a community hospital.
American journal of clinical oncology 1986;9(3):244-8.
1986: N S Tchekmedyian; K Newman; M R Moody; J W Costerton; Joseph Aisner; Stephen C Schimpff; W P Reed
Special studies of the Hickman catheter of a patient with recurrent bacteremia and candidemia.
The American journal of the medical sciences 1986;291(6):419-24.
1986: L M Sigman; David A Van Echo; Merrill J Egorin; M Y Whitacre; Joseph Aisner
Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.
Cancer treatment reports 1986;70(6):721-5.
1986: I N Olver; R M Simon; Joseph Aisner
Antiemetic studies: a methodological discussion.
Cancer treatment reports 1986;70(5):555-63.
1986: I N Olver; Ross C Donehower; David A Van Echo; David S Ettinger; Joseph Aisner
Phase II trial of carboplatin in non-small cell lung cancer.
Cancer treatment reports 1986;70(3):421-2.
1986: Merrill J Egorin; David A Van Echo; M Y Whitacre; A Forrest; L M Sigman; K L Engisch; Joseph Aisner
Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.
Cancer research 1986;46(3):1513-20.
1986: L M Sigman; David A Van Echo; M Y Whitacre; Joseph Aisner; D A Budman; P Shulman
Phase I trial of 5-day continuous infusion aziridinylbenzoquinone (AZQ, diazaquone, NSC 182968).
American journal of clinical oncology 1986;9(1):79-82.
1986: N S Tchekmedyian; Merrill J Egorin; B E Cohen; Richard S. Kaplan; E Poplin; Joseph Aisner
Phase I clinical and pharmacokinetic study of cyclophosphamide administered by five-day continuous intravenous infusion.
Cancer chemotherapy and pharmacology 1986;18(1):33-8.
1986: J Z Fuks; H Patel; J Hornedo; David A Van Echo; M Moody; Joseph Aisner
Infections in patients with non-small-cell lung cancer treated with intensive induction chemotherapy.
Medical and pediatric oncology 1986;14(5):255-61.
1985: Merrill J Egorin; David A Van Echo; E A Olman; M Y Whitacre; A Forrest; Joseph Aisner
Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum.
Cancer research 1985;45(12 Pt 1):6502-6.
1985: P J O'Dwyer; M Donehower; L M Sigman; C L Fortner; Joseph Aisner; David A Van Echo
Phase I trial of N-methylformamide (NMF, NSC 3051).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(6):853-7.
1985: Joseph Aisner; M Chatham
Pulmonary function to measure response in small cell lung cancer.
European journal of cancer & clinical oncology 1985;21(4):409-11.
1985: J Z Fuks; H Patel; David A Van Echo; J Hornedo; Joseph Aisner
Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer.
Medical and pediatric oncology 1985;13(2):73-7.
1985: J M Jones; E A Olman; Merrill J Egorin; Joseph Aisner
A case report and description of the pharmacokinetic behavior of intrapleurally instilled etoposide.
Cancer chemotherapy and pharmacology 1985;14(2):172-4.
1985: N Schnaper; S Tangerose; M N Wesley; Joseph Aisner
Training and oncologists' changing attitudes toward their own cancer therapy.
Medical and pediatric oncology 1985;13(5):293-7.
1984: Merrill J Egorin; David A Van Echo; S J Tipping; E A Olman; M Y Whitacre; B W Thompson; Joseph Aisner
Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.
Cancer research 1984;44(11):5432-8.
1984: Charles Alan Schiffer; D E Hogge; Joseph Aisner; J P Dutcher; Edward J Lee; D Papenberg
High-dose intravenous gammaglobulin in alloimmunized platelet transfusion recipients.
Blood 1984;64(4):937-40.
1984: David A Van Echo; Merrill J Egorin; M Y Whitacre; E A Olman; Joseph Aisner
Phase I clinical and pharmacologic trial of carboplatin daily for 5 days.
Cancer treatment reports 1984;68(9):1103-14.
1984: K H Antman; R L Ruxer; Joseph Aisner; G Vawter
Mesothelioma following Wilms' tumor in childhood.
Cancer 1984;54(2):367-9.
1984: D E Hogge; J P Dutcher; Joseph Aisner; Charles Alan Schiffer
The ineffectiveness of random donor platelet transfusion in splenectomized, alloimmunized recipients.
Blood 1984;64(1):253-6.
1984: K V Harwood; Joseph Aisner
Treatment of chemotherapy extravasation: current status.
Cancer treatment reports 1984;68(7-8):939-45.
1984: H Gerad; David A Van Echo; M Whitacre; M Ashman; M Helrich; J Foy; S Ostrow; P H Wiernik; Joseph Aisner
Doxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcoma.
Cancer 1984;53(12):2585-91.
1984: D C Tormey; V E Weinberg; L A Leone; O J Glidewell; M Perloff; B J Kennedy; E Cortes; R T Silver; Raymond B Weiss; Joseph Aisner
A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B study.
American journal of clinical oncology 1984;7(3):231-9.
1984: R S Aroney; W C Dermody; P Aldenderfer; P Parsons; K McNitt; P J Marangos; M Y Whitacre; R W Ruddon; P H Wiernik; Joseph Aisner
Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
Cancer treatment reports 1984;68(6):859-66.
1984: N O Whitley; J Z Fuks; E S McCrea; M Whitacre; J A Masler; J E Whitley; Joseph Aisner
Computed tomography of the chest in small cell lung cancer: potential new prognostic signs.
AJR. American journal of roentgenology 1984;142(5):885-92.
1984: J P Dutcher; Charles Alan Schiffer; Joseph Aisner; B A O'Connell; C Levy; J A Kendall; P H Wiernik
Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumors.
Cancer 1984;53(3):557-62.
1984: J P Dutcher; Joseph Aisner; D E Hogge; Charles Alan Schiffer
Donor reaction to hydroxyethyl starch during granulocytapheresis.
Transfusion 1984;24(1):66-7.
1983: Arlene A Forastiere; D R Budman; F Richards; Joseph Aisner; V Weinberg; W C Wood
Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study.
Cancer treatment reports 1983;67(12):1137-8.
1983: Charles Alan Schiffer; J P Dutcher; Joseph Aisner; D Hogge; P H Wiernik; J P Reilly
A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia.
Blood 1983;62(4):815-20.
1983: J P Dutcher; Charles Alan Schiffer; G S Johnston; D Papenburg; P A Daly; Joseph Aisner; P H Wiernik
Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection.
Blood 1983;62(2):354-60.
1983: Charles Alan Schiffer; Joseph Aisner; J P Dutcher; P H Wiernik
Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia.
American journal of hematology 1983;15(1):65-74.
1983: Charles Alan Schiffer; C Keller; J P Dutcher; Joseph Aisner; D Hogge; P H Wiernik
Potential HLA-matched platelet donor availability for alloimmunized patients.
Transfusion 1983;23(4):286-9.
1983: R S Aroney; Joseph Aisner; M N Wesley; M Y Whitacre; David A Van Echo; Robert Slawson; P H Wiernik
Value of prophylactic cranial irradiation given at complete remission in small cell lung carcinoma.
Cancer treatment reports 1983;67(7-8):675-82.
1983: D E Hogge; J P Dutcher; Joseph Aisner; Charles Alan Schiffer
Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion.
American journal of hematology 1983;14(4):363-9.
1983: K H Antman; E A Pomfret; Joseph Aisner; J MacIntyre; R T Osteen; J S Greenberger
Peritoneal mesothelioma: natural history and response to chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(6):386-91.
1983: J Z Fuks; David A Van Echo; C Garbino; H Kasdorf; Joseph Aisner
Treatment of advanced non-small cell lung cancer with bisantrene.
Cancer treatment reports 1983;67(6):597-8.
1983: J Z Fuks; Joseph Aisner; David A Van Echo; H Schipper; M Levitt; S Ostrow; P H Wiernik
Randomized study of cyclophosphamide, doxorubicin, and etoposide (VP16-213) with or without cisplatinum in non-small cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(5):295-301.
1983: C A de Jongh; J C Wade; R S Finley; J H Joshi; Joseph Aisner; P H Wiernik; Stephen C Schimpff
Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(5):302-7.
1983: Stuart E Mirvis; J P Dutcher; P J Haney; N O Whitley; Joseph Aisner
CT of malignant pleural mesothelioma.
AJR. American journal of roentgenology 1983;140(4):665-70.
1983: J Z Fuks; Joseph Aisner; David A Van Echo; M Levitt; D C Ihde; D Carney; P H Wiernik
Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung.
American journal of clinical oncology 1983;6(2):171-3.
1983: Seena Aisner; Joseph Aisner; CLAYTON MORAVEC; ERNEST ARNETT
Acquired toxoplasmic lymphadenitis with demonstration of the cyst form.
American journal of clinical pathology 1983;79(1):125-7.
1983: H Gerad; Merrill J Egorin; M Whitacre; David A Van Echo; Joseph Aisner
Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia.
Cancer chemotherapy and pharmacology 1983;11(3):162-6.
1983: Charles Alan Schiffer; Joseph Aisner; J P Dutcher
Platelet cryopreservation using dimethyl sulfoxide.
Annals of the New York Academy of Sciences 1983;411():161-9.
1983: Joseph Aisner; P Alberto; J Bitran; R Comis; J Daniels; H Hansen; H Ikegami; J Smyth
Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop.
Cancer treatment reports 1983;67(1):37-43.
1983: J Z Fuks; Merrill J Egorin; Joseph Aisner; David A Van Echo; S Ostrow; N R Bachur; P H Wiernik
Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma.
Cancer chemotherapy and pharmacology 1983;10(2):104-8.
1982: P H Konits; Joseph Aisner; J C Sutherland; P H Wiernik
Possible pulmonary toxicity secondary to vinblastine.
Cancer 1982;50(12):2771-4.
1982: D R Budman; Arlene A Forastiere; M Perloff; M Perry; Joseph Aisner; V Weinberg; W Wood
Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.
Cancer treatment reports 1982;66(10):1875-6.
1982: P H Konits; David A Van Echo; Joseph Aisner; D Morris; P H Wiernik
Doxorubicin plus VP-16-213 for the treatment of refractory breast carcinoma.
American journal of clinical oncology 1982;5(5):515-9.
1982: J Z Fuks; Joseph Aisner; David A Van Echo; P H Wiernik
Phase II study of medroxyprogesterone acetate with tamoxifen in advanced renal cell cancer.
Cancer treatment reports 1982;66(9):1773-4.
1982: Merrill J Egorin; Richard S. Kaplan; Michael Salcman; Joseph Aisner; M Colvin; P H Wiernik; N R Bachur
Cyclophosphamide plasma and cerebrospinal fluid kinetics with and without dimethyl sulfoxide.
Clinical pharmacology and therapeutics 1982;32(1):122-8.
1982: E A Poplin; Joseph Aisner; David A Van Echo; M Whitacre; P H Wiernik
CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma.
Cancer treatment reports 1982;66(7):1557-9.
1982: Joseph Aisner; D Morris; E G Elias; P H Wiernik
Mastectomy as an adjuvant to chemotherapy for locally advanced or metastatic breast cancer.
Archives of surgery (Chicago, Ill. : 1960) 1982;117(7):882-7.
1982: Dean E Brenner; C Garbino; H Kasdorf; U Villasanta; R Polcaro; J Yovarone; Joseph Aisner; Charles Alan Schiffer; P H Wiernik
A phase II trial of m-AMSA in the treatment of advanced gynecologic malignancies.
American journal of clinical oncology 1982;5(3):291-5.
1982: J Z Fuks; David A Van Echo; Joseph Aisner; H Schipper; M Levitt; P H Wiernik
Phase II evaluation of AMSA in patients with stage III--IV malignant melanoma.
Cancer treatment reports 1982;66(5):1237-8.
1982: David A Van Echo; M Y Whitacre; Joseph Aisner; M M Applefeld; P H Wiernik
Phase I trial of aclacinomycin A.
Cancer treatment reports 1982;66(5):1127-32.
1982: Dean E Brenner; N O Whitley; T L Houk; Joseph Aisner; P Wiernik; J Whitley
Volume determinations in computed tomography.
JAMA : the journal of the American Medical Association 1982;247(9):1299-302.
1982: N O Whitley; Dean E Brenner; A Francis; U Villa Santa; Joseph Aisner; P H Wiernik; J Whitley
Computed tomographic evaluation of carcinoma of the cervix.
Radiology 1982;142(2):439-46.
1982: J Z Fuks; Joseph Aisner; D N Carney; David A Van Echo; S S Ostrow; D C Ihde; P H Wiernik
A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
American journal of clinical oncology 1982;5(1):49-52.
1982: Joseph Aisner; M Whitacre; David A Van Echo; P H Wiernik
Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Cancer treatment reports 1982;66(2):221-30.
1982: J Z Fuks; Joseph Aisner; P H Wiernik
Restaging laparotomy in the management of the non-Hodgkin lymphomas.
Medical and pediatric oncology 1982;10(5):429-38.
1982: P H Konits; Merrill J Egorin; David A Van Echo; Joseph Aisner; P A Andrews; M E May; N R Bachur; P H Wiernik
Phase II evaluation and plasma pharmacokinetics of high-dose intravenous 6-thioguanine in patients with colorectal carcinoma.
Cancer chemotherapy and pharmacology 1982;8(2):199-203.
1982: Charles Alan Schiffer; Joseph Aisner; J P Dutcher; P A Daly; P H Wiernik
A clinical program of platelet cryopreservation.
Progress in clinical and biological research 1982;88():165-80.
1982: Joseph Aisner; David A Van Echo; M Whitacre; P H Wiernik
A phase I trial of continuous infusion VP16-213 (etoposide).
Cancer chemotherapy and pharmacology 1982;7(2-3):157-60.
1982: P H Konits; Joseph Aisner; M Whitacre; P H Wiernik
Lung cancer as a complication of prolonged survival in patients with lymphoma.
Medical and pediatric oncology 1982;10(4):331-8.
1982: Joseph Aisner; M Whitacre; D A VanEcho; M Wesley; P H Wiernik
Doxorubicin, Cyclophosphamide and VP16-213 (ACE) in the treatment of small cell lung cancer.
Cancer chemotherapy and pharmacology 1982;7(2-3):187-93.
1982: S T Rosen; Joseph Aisner; R W Makuch; M J Matthews; D C Ihde; M Whitacre; E J Glatstein; P H Wiernik; A S Lichter; P A Bunn
Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experience.
Medicine 1982;61(1):45-53.
1981: N Whitley; Dean E Brenner; A Francis; T Kwon; U Villasanta; Joseph Aisner; P Wiernik; J Whitley
Use of the computed tomographic whole body scanner to stage and follow patients with advanced ovarian carcinoma.
Investigative radiology 1981;16(6):479-86.
1981: Joseph Aisner; H H Hansen
Commentary: current status of chemotherapy for non-small cell lung cancer.
Cancer treatment reports 1981;65(11-12):979-86.
1981: J P Dutcher; Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized.
Blood 1981;58(5):1007-11.
1981: P H Konits; Joseph Aisner; David A Van Echo; K Lichtenfeld; P H Wiernik
Mitomycin C and vinblastine chemotherapy for advanced breast cancer.
Cancer 1981;48(6):1295-8.
1981: Joseph Aisner; P H Wiernik
Chemotherapy in the treatment of malignant mesothelioma.
Seminars in oncology 1981;8(3):335-43.
1981: Joseph Aisner; P H Wiernik
Asbestos-related neoplasms. Introduction.
Seminars in oncology 1981;8(3):241-2.
1981: David A Van Echo; M Y Whitacre; Joseph Aisner; P H Wiernik
Phase I trial of dihydroxyanthracenedione.
Cancer treatment reports 1981;65(9-10):831-4.
1981: C E Riggs; Merrill J Egorin; J Z Fuks; N Schnaper; P Duffey; O M Colvin; Joseph Aisner; P H Wiernik; N R Bachur
Initial observations on the effects of delta 9-tetrahydrocannabinol on the plasma pharmacokinetics of cyclophosphamide and doxorubicin.
Journal of clinical pharmacology 1981;21(8-9 Suppl):90S-98S.
1981: Dean E Brenner; N O Whitley; W Z Goldstein; Joseph Aisner
Computed tomographic demonstration of peritoneal mesothelioma.
Lancet 1981;1(8226):939-40.
1981: J P Dutcher; Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Alloimmunization following platelet transfusion: the absence of a dose-response relationship.
Blood 1981;57(3):395-8.
1981: S Ostrow; David A Van Echo; M Whitacre; Joseph Aisner; R Simon; P H Wiernik
Physiologic response and toxicity in patients undergoing whole-body hyperthermia for the treatment of cancer.
Cancer treatment reports 1981;65(3-4):323-5.
1981: Joseph Aisner; Charles Alan Schiffer; P A Daly; D H Buchholz
Evaluation of gravity leukapheresis and comparison with intermittent centrifugation leukapheresis.
Transfusion 1981;21(1):100-6.
1981: J Z Fuks; David A Van Echo; Joseph Aisner; E P Mitchell; P V Woolley; P H Wiernik
Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinoma.
Cancer clinical trials 1981;4(4):411-4.
1981: J Z Fuks; Merrill J Egorin; Joseph Aisner; S S Ostrow; M E Klein; N R Bachur; M Colvin; P H Wiernik
Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics.
Cancer chemotherapy and pharmacology 1981;6(2):117-20.
1981: S Ostrow; Merrill J Egorin; D Hahn; S Markus; Joseph Aisner; P Chang; A LeRoy; N R Bachur; P H Wiernik
High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity.
Cancer treatment reports 1981;65(1-2):73-8.
1981: J Z Fuks; David A Van Echo; Joseph Aisner; Daniel Von Hoff; P H Wiernik
Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung.
Cancer treatment reports 1981;65(1-2):133-4.
1981: Joseph Aisner; S Ostrow; S Govindan; P H Wiernik
Leptomeningeal carcinomatosis in small cell carcinoma of the lung.
Medical and pediatric oncology 1981;9(1):47-59.
1980: Joseph Aisner; P H Wiernik
Chemotherapy versus chemoimmunotherapy for small-cell undifferentiated carcinoma of the lung.
Cancer 1980;46(12):2543-9.
1980: J R Hankins; J R Satterfield; Joseph Aisner; P H Wiernik; Joseph S McLaughlin
Pericardial window for malignant pericardial effusion.
The Annals of thoracic surgery 1980;30(5):465-71.
1980: David A Van Echo; S Markus; Joseph Aisner; P H Wiernik
Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
Cancer treatment reports 1980;64(8-9):1009-10.
1980: L C Burks; Joseph Aisner; C L Fortner; P H Wiernik
Meperidine for the treatment of shaking chills and fever.
Archives of internal medicine 1980;140(4):483-4.
1980: P A Daly; Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations.
JAMA : the journal of the American Medical Association 1980;243(5):435-8.
1980: S Ostrow; Merrill J Egorin; Joseph Aisner; N Bachur; P H Wiernik
High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy.
Cancer clinical trials 1980;3(1):23-7.
1980: David A Van Echo; P H Wiernik; Joseph Aisner
High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemia.
Cancer clinical trials 1980;3(4):325-8.
1980: David A Van Echo; D F Chiuten; M Whitacre; Joseph Aisner; J L Lichtenfeld; P H Wiernik
Phase I trial of pentamethylmelamine in patients with previously treated malignancies.
Cancer treatment reports 1980;64(12):1335-9.
1980: Dean E Brenner; Joseph Aisner; P H Wiernik
Severe skin necrosis produced by piperazinedione extravasation.
Cancer treatment reports 1980;64(12):1392-4.
1979: P A Daly; Charles Alan Schiffer; Joseph Aisner; P H Wiernik
A comparison of platelets prepared by the Haemonetics Model 30 and multiunit bag plateletpheresis.
Transfusion 1979;19(6):778-81.
1979: P A Daly; Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Successful transfusion of platelets cryopreserved for more than 3 years.
Blood 1979;54(5):1023-7.
1979: Charles Alan Schiffer; Joseph Aisner; P A Daly; Stephen C Schimpff; P H Wiernik
Alloimmunization following prophylactic granulocyte transfusion.
Blood 1979;54(4):766-74.
1979: Joseph Aisner; Seena Aisner; S Ostrow; S Govindan; K Mummert; P Wiernik
Meningeal carcinomatosis from small cell carcinoma of the lung. Consequence of improved survival.
Acta cytologica 1979;23(4):292-9.
1979: Joseph Aisner; Douglas Ross; P H Wiernik
Tamoxifen in advanced male breast cancer.
Archives of internal medicine 1979;139(4):480-1.
1979: P Dombernowsky; S Sörenson; Joseph Aisner; H H Hansen
cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study.
Cancer treatment reports 1979;63(4):543-5.
1979: Charles Alan Schiffer; Joseph Aisner; P A Daly; P H Wiernik
Increased leukocyte alkaline phosphatase activity following transfusion of leukocytes from a patient with chronic myelogenous leukemia.
The American journal of medicine 1979;66(3):519-22.
1979: P A Daly; R Simon; Charles Alan Schiffer; Joseph Aisner; P I Terasaki; P H Wiernik
A study of HLA antigens and haplotypes in a population of Caucasians with acute non-lymphocytic leukemia.
Leukemia research 1979;3(2):75-82.
1979: Joseph Aisner; Charles Alan Schiffer; S Hedmann; P H Wiernik
Gravity leukapheresis--a simple method of leukocyte collection for transfusion or in vitro study.
Leukemia research 1979;3(1):1-5.
1979: L H Maurer; R B Weiss; Joseph Aisner
Streptozotocin: an inactive agent in small cell carcinoma.
Cancer clinical trials 1979;2(1):59-61.
1979: Joseph Aisner; J Murillo; Stephen C Schimpff; A C Steere
Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use.
Annals of internal medicine 1979;90(1):4-9.
1978: Charles Alan Schiffer; Joseph Aisner
Filtration leukapheresis (FL) and granulocytes.
Blood 1978;52(6):1249-50.
1978: Joseph Aisner; P H Wiernik
Malignant mesothelioma. Current status and future prospects.
Chest 1978;74(4):438-44.
1978: R J Esterhay; Joseph Aisner; J A Levi; P H Wiernik
High-dose 6-mercaptopurine in advanced refractory cancer.
Cancer treatment reports 1978;62(8):1229-31.
1978: Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Frozen autologous platelet transfusion for patients with leukemia.
The New England journal of medicine 1978;299(1):7-12.
1978: Stephen C Schimpff; Joseph Aisner
Empiric antibiotic therapy.
Cancer treatment reports 1978;62(5):673-80.
1978: Joseph Aisner; J R Satterfield; Seena Aisner; J C Pyeatte; P H Wiernik
Inflammatory changes related to active tuberculosis: confusion with oat cell carcinoma of the lung on cytology specimens.
Chest 1978;73(5):670-2.
1978: D Morris; Joseph Aisner; E G Elias; P H Wiernik
Mastectomy as an adjunct to combination chemotherapy.
Archives of surgery (Chicago, Ill. : 1960) 1978;113(3):282-4.
1978: Joseph Aisner; P H Wiernik
[Chemotherapy in recurrent and inoperable breast neoplasms].
Nowotwory 1978;28(1):80-9.
1978: Joseph Aisner; Charles Alan Schiffer; P H Wiernik
Granulocyte transfusions: evaluation of factors influencing results and a comparison of filtration and intermittent centrifugation leukapheresis.
British journal of haematology 1978;38(1):121-9.
1978: Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Platelet transfusion therapy for patients with leukemia.
Progress in clinical and biological research 1978;28():267-79.
1978: Joseph Aisner
Specialty rounds. Management of disseminated carcinoma of the breast.
The American journal of the medical sciences 1978;275(1):5-16.
1977: Charles Alan Schiffer; Joseph Aisner
Failure of postfiltration leukapheresis plasma to increase granulocyte yields.
Transfusion 1977;17(5):500-2.
1977: Joseph Aisner
Platelet transfusion therapy.
The Medical clinics of North America 1977;61(5):1133-45.
1977: Charles Alan Schiffer; F T Sanel; V B Young; Joseph Aisner
Reversal of granulocyte adherence to nylon fibers using local anesthetic agents: possible application to filtration leukapheresis.
Blood 1977;50(2):213-25.
1977: D Morris; Joseph Aisner; P H Wiernik
Horizontal pigmented banding of the nails in association with adriamycin chemotherapy.
Cancer treatment reports 1977;61(3):499-501.
1977: Joseph Aisner; P H Wiernik; Stephen C Schimpff
Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response.
Annals of internal medicine 1977;86(5):539-43.
1977: Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Current status of granulocyte transfusion therapy.
Progress in clinical and biological research 1977;13():281-92.
1976: Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Clinical experience with transfusion of cryopreserved platelets.
British journal of haematology 1976;34(3):377-85.
1976: Joseph Aisner; Charles Alan Schiffer; J H Wolff; P H Wiernik
A standardized technique for efficient platelet and leukocyte collection using the Model 30 Blood Processor.
Transfusion 1976;16(5):437-45.
1976: Charles Alan Schiffer; C L Whitaker; M Schmukler; Joseph Aisner; S L Hilbert
The effect of dimethyl sulfoxide on in vitro platelet function.
Thrombosis and haemostasis 1976;36(1):221-9.
1976: Charles Alan Schiffer; D H Buchholz; Joseph Aisner; J H Wolff; P H Wiernik
Frozen autologous platelets in the supportive care of patients with leukemia.
Transfusion 1976;16(4):321-9.
1976: Joseph Aisner; Stephen C Schimpff; J C Sutherland; V M Young; P H Wiernik
Torulopsis glabrata infections in patients with cancer. Increasing incidence and relationship to colonization.
The American journal of medicine 1976;61(1):23-8.
1976: F T Sanel; Joseph Aisner; Charles Alan Schiffer
Letter: Filtration leukopheresis.
Blood 1976;47(5):877-9.
1976: Joseph Aisner; L K Kvols; Edward A Sickles; Stephen C Schimpff; P H Wiernik
Transtracheal selective bronchial brushing for pulmonary infiltrates in patients with cancer.
Chest 1976;69(3):367-71.
1976: Joseph Aisner; Stephen C Schimpff; JOHN BENNETT; V M Young; P H Wiernik
Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital.
JAMA : the journal of the American Medical Association 1976;235(4):411-12.
1976: P H Wiernik; Stephen C Schimpff; Charles Alan Schiffer; J L Lichtenfeld; Joseph Aisner; M J O'Connell; C Fortner
Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
Cancer treatment reports 1976;60(1):41-53.
1975: Charles Alan Schiffer; Joseph Aisner; M Schmukler; C L Whitaker; J H Wolff
The effect of hydroxyethyl starch on in vitro platelet and granulocyte function.
Transfusion 1975;15(5):473-5.
1975: Charles Alan Schiffer; D H Buchholz; Joseph Aisner; S W Betts; P H Wiernik
Clinical experience with transfusion of granulocytes obtained by continuous flow filtration leukopheresis.
The American journal of medicine 1975;58(3):373-81.
1975: Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Transient neutropenia induced by transfusion of blood exposed to nylon fiber filters.
Blood 1975;45(1):141-6.
1974: W H Greene; M Moody; R Hartley; E Effman; Joseph Aisner; V M Young; R H Wiernik
Esophagoscopy as a source of Pseudomonas aeruginosa sepsis in patients with acute leukemia: the need for sterilization of endoscopes.
Gastroenterology 1974;67(5):912-9.
1974: Joseph Aisner; Edward A Sickles; Stephen C Schimpff; V M Young; W H Greene; P H Wiernik
Torulopsis glabrata pneumonitis in patients with cancer. Report of three cases.
JAMA : the journal of the American Medical Association 1974;230(4):584-5.